Skip to main content
. 2017 Feb 23;8(15):24250–24261. doi: 10.18632/oncotarget.15653

Table 3. Comparison of overall marker intensities between negative vs PDAC specimens.

Covariate Signal Intensity, CU/ug (Mean ± SD, median) P value
Negative (N=10) PDAC (N=70)
Total Cytokeratin (CK) 116.76 ± 167.12, 47.15 536.93 ± 733.89, 354.25 0.002
Phospho-HER1 4.17 ± 5.76, 1.89 1.95 ± 2.65, 1.03 0.234
Phospho-HER2 0.33 ± 0.35, 0.14 2.78 ± 4.2, 1.15 0.007
Phospho-HER3 14.12 ± 14.84, 7.65 38.36 ± 45.71, 22.98 0.026
Phospho-c-MET 0.15 ± 0.16, 0.05 0.76 ± 1.46, 0.26 0.051
Phospho-IGFR 37.30 ± 47.26, 29.16 25.61 ± 45.06, 12.06 0.363
Phospho-PI3K 46.37 ± 44.40, 25.17 33.49 ± 32.5, 28.93 0.399
Phospho-SHC 3.23 ± 4.14, 1.84 5.56 ± 5.62, 4.21 0.200
Total HER1 54.38 ± 47.42, 42 61.44 ± 62.16, 40.25 0.765
Total HER2 1.22 ± 1.26, 0.55 10.18 ± 14.46, 3.9 0.006
Total HER3 54.72 ± 66.72, 25.0 387.96 ± 722.64, 120.2 0.008
Total c-MET 72.65 ± 66.73, 60.0 441.29 ± 649.53, 288.05 <0.001
Total IGFR 23.82 ± 15.67, 15.0 83.69 ± 108.82, 43.34 0.012
Phospho-AKT 0.80 ± 1.23, 0.26 3.25 ± 5.47, 1.36 0.046
Phospho-ERK1/2 0.92 ± 0.86, 0.88 7.8 ± 10.66, 4.78 <0.001
Phospho-MEK 0.36 ± 0.21, 0.43 1.77 ± 2.54, 0.74 0.120
Phospho-RSK 24.06 ± 17.89, 14.94 80.26 ± 80.7, 48.02 0.127
Phospho-PRAS40 12.61 ± 28.33, 1.0 41.6 ± 68.5, 9.24 0.043
Phospho-RPS6 50.13 ± 87.00, 4.84 18.74 ± 60.08, 1.58 0.377